Cargando…

Risk Factors for Ocular Chlamydia after Three Mass Azithromycin Distributions

BACKGROUND: An important component of the World Health Organization's comprehensive trachoma elimination strategy is the provision of repeated annual mass azithromycin distributions, which are directed at reducing the burden of ocular chlamydia. Knowledge of characteristics associated with infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayele, Berhan, Gebre, Teshome, Moncada, Jeanne, House, Jenafir I., Stoller, Nicole E., Zhou, Zhaoxia, Porco, Travis C., Gaynor, Bruce D., Emerson, Paul M., Schachter, Julius, Keenan, Jeremy D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236733/ https://www.ncbi.nlm.nih.gov/pubmed/22180804 http://dx.doi.org/10.1371/journal.pntd.0001441

Ejemplares similares

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Reliability of Measurements Performed by Community-Drawn Anthropometrists from Rural Ethiopia
por: Ayele, Berhan, et al.
Publicado: (2012)

Antibiotic Selection Pressure and Macrolide Resistance in Nasopharyngeal Streptococcus pneumoniae: A Cluster-Randomized Clinical Trial
por: Skalet, Alison H., et al.
Publicado: (2010)

Community Risk Factors for Ocular Chlamydia Infection in Niger: Pre-Treatment Results from a Cluster-Randomized Trachoma Trial
por: Amza, Abdou, et al.
Publicado: (2012)

Does Mass Azithromycin Distribution Impact Child Growth and Nutrition in Niger? A Cluster-Randomized Trial
por: Amza, Abdou, et al.
Publicado: (2014)

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
por: Lietman, Thomas M., et al.
Publicado: (2015)

A Cluster-Randomized Controlled Trial Evaluating the Effects of Mass Azithromycin Treatment on Growth and Nutrition in Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Importance of Coverage and Endemicity on the Return of Infectious Trachoma after a Single Mass Antibiotic Distribution
por: Lakew, Takele, et al.
Publicado: (2009)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
por: Liu, Fengchen, et al.
Publicado: (2014)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Concordance of ompA types in children re-infected with ocular Chlamydia trachomatis following mass azithromycin treatment for trachoma
por: Mosenia, Arman, et al.
Publicado: (2022)

The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial
por: O'Brien, Kieran S., et al.
Publicado: (2017)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopia
por: Nash, Scott D., et al.
Publicado: (2020)

Elimination and Eradication of Neglected Tropical Diseases with Mass Drug Administrations: A Survey of Experts
por: Keenan, Jeremy D., et al.
Publicado: (2013)

Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II)
por: Keenan, Jeremy D., et al.
Publicado: (2018)

Reduction and Return of Infectious Trachoma in Severely Affected Communities in Ethiopia
por: Lakew, Takele, et al.
Publicado: (2009)

A rationale for continuing mass antibiotic distributions for trachoma
por: Ray, Kathryn J, et al.
Publicado: (2007)

Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial
por: Porco, Travis C, et al.
Publicado: (2019)

MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2018)

Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa
por: Keenan, Jeremy D, et al.
Publicado: (2018)

Prevalence of Trachoma at Sub-District Level in Ethiopia: Determining When to Stop Mass Azithromycin Distribution
por: King, Jonathan D., et al.
Publicado: (2014)

High rates of persistent and recurrent chlamydia in pregnant women after treatment with azithromycin
por: Dionne-Odom, Jodie, et al.
Publicado: (2020)

Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
por: Tamarelle, Jeanne, et al.
Publicado: (2020)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

Ocular Chlamydia trachomatis Infection Under the Surgery, Antibiotics, Facial Cleanliness, and Environmental Improvement Strategy in Amhara, Ethiopia, 2011–2015
por: Nash, Scott D, et al.
Publicado: (2018)

Reliability of Trachoma Clinical Grading—Assessing Grading of Marginal Cases
por: Rahman, Salman A., et al.
Publicado: (2014)

Post-antibiotic Ocular Surface Microbiome in Children: A Cluster-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions
por: Porco, Travis C., et al.
Publicado: (2020)

Liposomal Encapsulation Increases the Efficacy of Azithromycin against Chlamydia trachomatis
por: Bogdanov, Anita, et al.
Publicado: (2021)

Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Optimal Seasonal Timing of Oral Azithromycin for Malaria
por: Gao, Daozhou, et al.
Publicado: (2014)

Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis
por: Mohammadzadeh, Farnaz, et al.
Publicado: (2019)

Single Dose of Azithromycin for Treatment of Patients with Asymptomatic Rectal Chlamydia trachomatis
por: MACAUX, Lou, et al.
Publicado: (2020)

Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mkkegnajfgk3t27bbjc6cffm30